To examine the status of pharmaceutical industry support for junior residency education in Japan, we performed a questionnaire survey of 445 residency program directors （response rate, 76%）.
1） Fifty-one percent of respondents thought that industry support was necessary for education, and 28% did not believe that industry support negatively affects residents’ prescribing behaviors.
2） Twelve percent said their institutions had a curriculum for physician-industry relationships. Ten percent prohibit residents from meeting with pharmaceutical representatives, and 30% ban gifts from industry.
3） Fifty-one percent reported that they had pharmaceutical industry-sponsored in-hospital educational events for residents, and 73% reported that they had industry-sponsored in-hospital educational events which residents were allowed to attend.
4） Program directors’ belief that industry support was necessary for education predicted that programs would receive such support.

OBJECTIVEThe relation between daily maximum temperature and mortality rate has a V-shaped pattern; the mortality rate is lowest at a certain temperature, that is, optimum temperature (OT), and the mortality rate increases when the temperature becomes higher or lower than OT. OT is associated with climate, but the relation between OT and long-term average temperature, which is a frequently used index of climate, had an outlier (Okinawa) even in Japan alone. Our objective is to determine the best climate index for OT estimation.

METHODSWe obtained death certificate data, meteorological data and population data for Japan from relevant government ministries. All the data obtained were from 1972 to 1995 except for Okinawa's mortality data (1973 to 1995). Using smoothing spline with the degree of freedom fixed to 6, we computed the OTs for 47 prefectures in Japan. These OTs were exhaustively compared with percentiles of daily maximum, average, and minimum temperatures, along with the long-term average temperature.

RESULTSAmong the candidates of the best climate index, 80 and 85 percentiles of daily maximum temperatures (Tmax80 and Tmax85) showed the highest correlation coefficient with OT (R>0.9, much higher than the R for the long-term average temperature, i.e., 0.63), and the regression models using Tmax80 and Tmax85 best regressed the OT, that is, the difference between the observed OT and the expected OT was smallest when Tmax80 or Tmax85 was used. Unlike previously used average of daily mean temperature, Tmax80 and Tmax85 made Okinawa a nonoutlier. This characteristic is desirable because Okinawa's being an outlier is due to its maritime climate and the capacity to accommodate a different type of climate may expand the applicability of OT estimation method to wider regions in the world. A direct comparison of OT with Tmax75 to Tmax90 revealed that the difference is smallest for the percentile between Tmax80 and Tmax85.

CONCLUSIONWe considered that a daily maximum temperature between Tmax80 and Tmax85 is the best climate index for estimating OT in Japan.

Background/Aims: Thromboprophylaxis is recommended for hospitalized patients with inflammatory bowel disease (IBD) in Western countries, although it is selectively administered to high-risk patients in East Asia. A central venous catheter (CVC) is commonly placed in patients with IBD. Although CVC placement is considered a risk factor for venous thromboembolism (VTE), the degree of increased risk in patients with IBD is uncertain. This study aimed to identify the risk of VTE with CVC placement in hospitalized Japanese patients with IBD without thromboprophylaxis. Methods: This retrospective cohort study included patients with ulcerative colitis or Crohn’s disease who were admitted for disease flares at Keio University Hospital between January 2016 and December 2020. Patients who already had thrombosis or were administered any antithrombotic treatment on admission were excluded. VTE development during the hospitalization was surveyed, and VTE risk associated with CVC indwelling was estimated using propensity score matching and inverse probability of treatment weighting analyses. Results: Altogether, 497 hospitalized patients with IBD (ulcerative colitis, 327; Crohn’s disease, 170) were enrolled. VTE developed in 9.30% (12/129) of catheterized patients and in 0.82% (3/368) of non-catheterized patients. The propensity score matching yielded 127 matched pairs of patients. The catheterized group demonstrated higher odds for VTE than the non-catheterized group (odds ratio, 13.15; 95% confidence interval, 1.68–102.70). A similar result was obtained in the inverse probability of treatment weighting analysis (odds ratio, 11.02; 95% confidence interval, 2.64–46.10). Conclusions CVC placement is a major risk factor for VTE among hospitalized Japanese patients with IBD without thromboprophylaxis.

Ulcerative colitis (UC) is one of the major clinical phenotypes of inflammatory bowel diseases. Although 5-aminosalicylic acid (5-ASA) is widely used for UC and its efficacy and safety have been demonstrated, a few patients paradoxically develop a severe exacerbation of colitis by 5-ASA administration. It is crucial to know clinical features including endoscopic findings in this condition for making a correct diagnosis and a prompt decision to withdraw the medication. Here, we report case series with UC exacerbated by 5-ASA. Medical records of 8 UC patients experiencing an exacerbation of colitis after induction of 5-ASA that was improved by the withdrawal of 5-ASA but also re-aggravated by dose increase or re-administration of 5-ASA were reviewed. The patients were newly diagnosed with UC, started 5-ASA and developed an exacerbation in approximately 2 to 3 weeks. They did not appear to have systemic allergic reactions. Seven of the 8 patients had a high fever. Three of 5 patients who undertook total colonoscopy showed right-side-dominant colitis. These findings suggest clinical characteristics in this condition. Further assessment of clinical and endoscopic features in more cases is necessary for establishing diagnostic criteria and understanding underlying mechanisms in those cases where 5-ASA aggravates the colitis.
Colitis* ; Colitis, Ulcerative* ; Colonoscopy ; Diagnosis ; Fever ; Humans ; Hypersensitivity ; Inflammatory Bowel Diseases ; Medical Records ; Mesalamine* ; Phenotype ; Ulcer*